New bronchitis drug shows promise in large trial

NCT ID NCT07111468

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This Phase 3 trial tested a new drug called YHP2401 against two other drugs for acute bronchitis. 286 adults with cough and phlegm took one of the treatments for 7 days. The goal was to see if YHP2401 works better at reducing symptoms.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
YHP2401 (an experimental drug for acute bronchitis)
What this could lead to
If it works, this could offer a more effective treatment for acute bronchitis symptoms like cough and phlegm.
What could go wrong
This is a completed Phase 3 trial, but results are not yet public. The drug may not prove superior to existing treatments, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE BRONCHITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hallym University Chuncheon Sacred Heart Hospital

    Chuncheon, 24253, South Korea

  • Kangbuk Samsung Hospital

    Seoul, 03181, South Korea

  • Kangdong Sacred Heart Hospital

    Seoul, 05355, South Korea

  • Konkuk University Medical Center

    Seoul, 05030, South Korea

  • Korea University Guro Hospital

    Seoul, 08308, South Korea

  • SMG-SNU Boramae Medical Center

    Seoul, 07061, South Korea

  • Soonchunhyang University Hospital Bucheon

    Bucheon-si, 14584, South Korea

  • The Catholic University of Korea, Eunpyeong St.Mary's Hospital

    Seoul, 03312, South Korea

  • The Catholic University of Korea, Uijeongbu St. Mary's Hospital

    Uijeongbu-si, 11765, South Korea

  • Ulsan University Hospital

    Ulsan, 44033, South Korea

  • Wonkwang University Hospital

    Iksan, 54538, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.